Summary & Overview
HCPCS G9467: Chronic Systemic Corticosteroid Exposure
HCPCS Level II code G9467 documents patients with sustained or high cumulative systemic corticosteroid exposure: either at least 10 mg/day prednisone equivalent for 60+ consecutive days or a single prescription totaling 600 mg prednisone or more across fills in the prior 12 months. Nationally, this marker matters because prolonged or high-dose corticosteroid use is associated with increased risk of infections, osteoporosis, adrenal suppression, and other complications, and it can affect care coordination and quality measurement. Key payers included in this review are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will gain a concise clinical and billing orientation to the code, understand typical sites of service and service type, and find an overview of what to expect when the code is used for monitoring medication exposure. The publication highlights policy and documentation context, common operational considerations for outpatient and pharmacy settings, and identifies where additional information was not provided. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code G9467 identifies patients who have received or are receiving systemic corticosteroid therapy at a dose of ≥10 mg/day prednisone equivalent for 60 or more consecutive days, or who have a single prescription equating to ≥600 mg prednisone for all fills within the last 12 months. This definition captures sustained or high cumulative corticosteroid exposure relevant to risk stratification and care planning.
-
Service type: Medication exposure monitoring and risk classification related to chronic systemic corticosteroid use.
-
Typical site of service: Outpatient clinics, specialty practices (for example rheumatology, pulmonology, gastroenterology), infusion centers, and pharmacy dispensing settings where long-term corticosteroid therapy is prescribed, managed, or documented.
Clinical & Coding Specifications
Clinical Context
A 62-year-old male with moderate-to-severe chronic obstructive pulmonary disease (COPD) and polymyalgia rheumatica has been treated with long-term oral corticosteroids. Over the past 10 months he has had multiple prescriptions that average at least 10 mg prednisone equivalent per day, and one fill equating to 600 mg prednisone total within the last twelve months. During a routine specialty visit in the outpatient pulmonology clinic, the clinician documents the cumulative corticosteroid exposure and assesses steroid-related risk factors (osteoporosis risk, infection risk, glycemic control). The clinical workflow includes medication reconciliation, review of prescription fill history, problem-list verification, and coding of the corticosteroid exposure for quality reporting and risk stratification.
Typical site of service is outpatient clinic or specialty ambulatory care (pulmonology, rheumatology, or primary care). The service documents chronic systemic corticosteroid exposure meeting the thresholds described by billing code G9467 and supports clinical decision-making such as bone density screening, vaccination review, and infection surveillance. Encounter documentation includes dates and dosages of corticosteroid fills, total prednisone-equivalent calculations, clinical indication, and any management steps taken related to steroid adverse effects.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|